☆ 4.6 Article

Dispensing anti-osteoporotic drugs changed during the COVID-19 pandemic

BONE (2022)

Related references

Note: Only part of the references are listed.

Article Primary Health Care

Impact of the COVID-19 Pandemic on Primary Health Care Disease Incidence Rates: 2017 to 2020

Antoni Siso-Almirall et al.

Summary: The COVID-19 pandemic has significantly impacted the incidence rates of common primary care diseases in Spain, mainly due to the prioritization of healthcare resources leading to a decrease in detection and management of chronic diseases.

ANNALS OF FAMILY MEDICINE (2022)

Add to Collection

Article Endocrinology & Metabolism

No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study

A. Atmaca et al.

Summary: This study evaluated the association between the use of anti-osteoporosis drugs in women and COVID-19 outcomes, finding that there was no significant impact on the risk of hospitalization, ICU admission, or mortality. The use of these drugs did not independently influence the outcomes of COVID-19.

OSTEOPOROSIS INTERNATIONAL (2022)

Add to Collection

Review Endocrinology & Metabolism

Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS

Elena Tsourdi et al.

Summary: Discontinuation of denosumab results in increased bone turnover, rapid bone loss, and risk of multiple vertebral fractures in some patients. Prior bisphosphonate therapy or subsequent antiresorptive treatment may help mitigate the biochemical rebound phenomenon after denosumab discontinuation.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Add to Collection

Article Endocrinology & Metabolism

The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study

E. McCloskey et al.

Summary: This study conducted in 8 European countries revealed a significant treatment gap in osteoporosis-related fracture risk management for elderly women in primary care, mainly due to the lack of osteoporosis diagnosis.

OSTEOPOROSIS INTERNATIONAL (2021)

Add to Collection

Article Endocrinology & Metabolism

Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures

E. V. McCloskey et al.

Summary: The COVID-19 pandemic has significantly impacted the management of osteoporosis, resulting in a decrease in access to online FRAX fracture risk assessments. Strategies to enhance osteoporosis care, including increased use of fracture risk assessments, are seen as a partial solution to address this issue.

OSTEOPOROSIS INTERNATIONAL (2021)

Add to Collection

Article

The Impact of COVID-19 on the Optimal Management of Osteoporosis

Sung Hye Kong et al.

Journal of Bone Metabolism (2021)

Add to Collection

Article Endocrinology & Metabolism

Joint position statement on management of patient with osteoporosis during COVID-19 contingency from the AMMOM, CONAMEGER, FELAEN, FEMECOG, FEMECOT, and ICAAFYD

Francisco Torres-Naranjo et al.

Summary: The joint position statement of Latin American Medical Societies provides an updated guide for the prevention, diagnosis, and treatment of osteoporotic patients in the face of possible clinical scenarios posed by the COVID-19 health crisis. A task force of bone specialists with representation from various professional associations collated clinical evidence and generated guidance statements to ensure optimal care for patients at risk for osteoporosis and fracture during the pandemic.

ARCHIVES OF OSTEOPOROSIS (2021)

Add to Collection

Article Endocrinology & Metabolism

Virtual fracture liaison clinics in the COVID era: an initiative to maintain fracture prevention services during the pandemic associated with positive patient experience

S. English et al.

Summary: Virtual fracture liaison clinics proved to be effective during the COVID-19 pandemic, delivering fracture risk assessment, health promotion, and clinical management with positive patient experience. While there is a need for follow-up DXA assessments, virtual clinics have successfully mitigated delays in fracture prevention interventions.

OSTEOPOROSIS INTERNATIONAL (2021)

Add to Collection

Article Endocrinology & Metabolism

How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey

N. R. Fuggle et al.

Summary: The effects of COVID-19 have impacted the management of chronic diseases, including osteoporosis, with increases in telemedicine consultations, delays in DXA scanning, interruptions in medication supply, and reductions in parenteral medication delivery observed globally.

OSTEOPOROSIS INTERNATIONAL (2021)

Add to Collection

Article Endocrinology & Metabolism

COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey

A. J. Singer et al.

OSTEOPOROSIS INTERNATIONAL (2021)

Add to Collection

Letter Endocrinology & Metabolism

Poor adherence to parenteral osteoporosis therapies during COVID-19 pandemic

Roland Kocijan et al.

ARCHIVES OF OSTEOPOROSIS (2021)

Add to Collection

Article Health Care Sciences & Services

Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions

Andrea L. Schaffer et al.

Summary: ARIMA modeling is a useful approach for evaluating the impact of large-scale interventions, especially when dealing with seasonality and autocorrelation. It can account for underlying trends, allow for flexible modeling of different impacts, and provide valuable insights for policy evaluation.

BMC MEDICAL RESEARCH METHODOLOGY (2021)

Add to Collection

Review Endocrinology & Metabolism

Diagnosis and Management of Osteoporosis During COVID-19: Systematic Review and Practical Guidance

G. Hampson et al.

Summary: The COVID-19 pandemic has disrupted the diagnosis and management of osteoporosis, but clinical recommendations and innovative care pathways can ensure continued treatment for patients and reduce fracture risks.

CALCIFIED TISSUE INTERNATIONAL (2021)

Add to Collection

Article Endocrinology & Metabolism

Vaccination for Coronavirus Disease 2019 (COVID-19) and Relationship to Osteoporosis Care: Current Evidence and Suggested Approaches

Elena Tsourdi et al.

Summary: The development of COVID-19 vaccines has been rapid and multiple vaccines are now approved for widespread distribution, with a focus on the older population. However, concerns have arisen regarding potential interactions with underlying diseases and treatments for those to be vaccinated.

JOURNAL OF BONE AND MINERAL RESEARCH (2021)

Add to Collection

Article Medicine, General & Internal

Impact of the 1st and 2nd Wave of the COVID-19 Pandemic on Primary or Revision Total Hip and Knee Arthroplasty-A Cross-Sectional Single Center Study

Sebastian Simon et al.

Summary: This study evaluated the impact of the COVID-19 pandemic on the number of primary and revision total joint arthroplasties in 2020 compared to 2019. It found a decrease in the number of TJA surgeries for both hip and knee in 2020, especially during the first wave of the pandemic.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Endocrinology & Metabolism

The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes

Luca Degli Esposti et al.

Summary: The study found that there was no significant correlation between the use of oral N-BPs treatment and the risk of severe COVID-19. The incidence of COVID-19 hospitalization, ICU utilization, and COVID-19-related mortality were similar in N-BPs users and nonusers.

JOURNAL OF BONE AND MINERAL RESEARCH (2021)

Add to Collection

Article Pediatrics

Prescription Drug Dispensing to US Children During the COVID-19 Pandemic

Kao-Ping Chua et al.

Summary: Prescription dispensing to children declined by one-quarter in April to December 2020 compared with April to December 2019, with greater declines seen in infection-related drugs than chronic disease drugs. Further investigation is needed to understand the reasons behind the decreased dispensing of chronic disease drugs and monitor whether reductions in dispensing of infection-related drugs are temporary or sustained.

PEDIATRICS (2021)

Add to Collection

Article Endocrinology & Metabolism

A pragmatic proposal for triaging DXA testing during the COVID-19 global pandemic

H. R. Sapkota et al.

Summary: We propose a simple algorithm to address increased DXA scan waiting lists during the COVID-19 pandemic, helping clinicians prioritize patients in need of urgent treatment and significantly reduce the number of DXA scans.

OSTEOPOROSIS INTERNATIONAL (2021)

Add to Collection

Review Hematology

Hematological findings and complications of COVID-19

Evangelos Terpos et al.

AMERICAN JOURNAL OF HEMATOLOGY (2020)

Add to Collection

Article Endocrinology & Metabolism

Osteoporosis in the age of COVID-19

C. M. Girgis et al.

OSTEOPOROSIS INTERNATIONAL (2020)

Add to Collection

Article Cell Biology

Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions

Josep Blanch-Rubio et al.

AGING-US (2020)

Add to Collection

Article Endocrinology & Metabolism

Identifying and managing osteoporosis before and after COVID-19: rise of the remote consultation?

Z. Paskins et al.

OSTEOPOROSIS INTERNATIONAL (2020)

Add to Collection

Letter Hematology

Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care Unit

Annalisa Boscolo et al.

THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020

Mark É. Czeisler et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Add to Collection

Letter Endocrinology & Metabolism

Are women with osteoporosis treated with denosumab at risk of severe COVID-19?

Anna Maria Formenti et al.

ENDOCRINE (2020)

Add to Collection

Article Endocrinology & Metabolism

Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension

Steven R. Cummings et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2018)

Add to Collection

© Peeref 2019-2024. All rights reserved.